hydralazine and temocapril hydrochloride

hydralazine has been researched along with temocapril hydrochloride in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koike, H; Miyamoto, M; Sada, T1
Iijima, Y; Koike, H; Nishino, H; Oda, T; Oizumi, K; Sada, T1
Araki, H; Gomita, Y; Kawasaki, H; Mimaki, Y; Nakatsuma, A; Okazaki, M1
Abe, Y; Kimura, S; Kiyomoto, H; Kobori, H; Kohno, M; Miyata, K; Miyatake, A; Nagai, Y; Nishiyama, A; Ozawa, Y; Shokoji, T; Yao, L; Yukimura, T1
Akiyama, S; Gessei-Tsutsumi, N; Goda, M; Hobara, N; Kawasaki, H; Kurosaki, Y; Takayama, F1

Trials

1 trial(s) available for hydralazine and temocapril hydrochloride

ArticleYear
Long-term inhibition of angiotensin converting enzyme suppresses calcium channel agonist-induced contraction of aorta in hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 1989, Volume: 14, Issue:6

    Topics: Animals; Aorta; Blood Pressure; Calcium Channel Agonists; Calcium Chloride; Dose-Response Relationship, Drug; Hydralazine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Potassium Chloride; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thiazepines

1989

Other Studies

4 other study(ies) available for hydralazine and temocapril hydrochloride

ArticleYear
Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR).
    Biochemical and biophysical research communications, 1988, Apr-15, Volume: 152, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Heart; Hydralazine; Kidney; Male; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Thiazepines

1988
Long-term treatment with angiotensin converting enzyme inhibitor restores reduced calcitonin gene-related peptide-containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats.
    Japanese journal of pharmacology, 1999, Volume: 79, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Captopril; Electric Stimulation; Hydralazine; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Pindolol; Rats; Rats, Inbred SHR; Thiazepines; Time Factors; Vascular Resistance; Vasodilation

1999
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.
    Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Hydralazine; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; NADPH Oxidases; Olmesartan Medoxomil; Prediabetic State; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Tetrazoles; Thiazepines; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta

2005
Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:5

    Topics: Aging; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcitonin Gene-Related Peptide; Cell Count; Hydralazine; Hypertension; Immunohistochemistry; Losartan; Male; Mesenteric Arteries; Nerve Fibers; Neuropeptide Y; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Sympathetic Nervous System; Thiazepines; Vasodilator Agents

2005